$C
C · Financials
- Market cap
- —
- Volume
- —
- P/E
- —
- Day range
- — – —
- 52w range
- — – —
- Analyst target
- —
AI Summary
Generating a unique summary for C…
AI-generated for information only — not investment advice.
Share this ticker
$C Warren Buffett and 3 other tracked billionaires hold it. $AXP $BAC $CB https://billionairestrading.com/stocks/C
Company summary
Global bank.
Institutional ownership
Institutions hold —% · insiders —%
No institutional filings available for this ticker.
Hedge fund & billionaire activity
Insider transactions
No insider transactions reported.
Analyst ratings
Consensus score — (1 = strong buy, 5 = sell) · mean target —
No recent analyst actions.
Earnings
Next report: not scheduled
No earnings history available.
SEC filings
No filings indexed for this ticker.
Latest C news
- DBS and Citi Just Settled a Weekend Cross-Border Payment in Minutes – and the Implications Go Beyond Banking Hours
On Saturday, September 5, 2026, DBS and Citi executed a cross-border USD payment that would have typically languished in the queue until Monday morning. Instead, the transaction settled in minutes. This was not a test of a private sandbox, but a live movement of value across Swift’s Digital Ledger, marking the second such transaction since […]
Mon, 07 Sep 2026 22:39:35 +0000
- DBS, Citi Complete First Weekend Cross-Border Payment
DBS (SGX: D05) and Citi (NYSE: $C) have completed a cross-border US dollar payment between Singapore and the United...
Mon, 07 Sep 2026 20:56:00 +0000
- Citigroup (C) Moves Deeper Into China’s Capital Markets as Competition Intensifies
Citigroup Inc. (NYSE:C) is reportedly expecting Chinese regulatory approval for its wholly owned mainland brokerage business as soon as September 2026. The bank applied for the licence in late 2021 and has spent the intervening years building out the business in preparation for approval. Citi now plans to roughly double the unit’s headcount to around […]
Mon, 07 Sep 2026 19:13:34 +0000
- Citi backs AstraZeneca sentiment boost after Etcamah wins accelerated FDA approval
Citi has flagged AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) accelerated approval for Etcamah, known chemically as camizestrant, as a meaningful sentiment driver for the shares. The oral selective oestrogen receptor degrader has been cleared by the US Food and Drug Administration in combination...
Mon, 07 Sep 2026 14:03:00 +0000
- Citigroup seeks China brokerage licence – report
The new business is expected to focus on industries including technology, healthcare, consumer and financial institutions.
Mon, 07 Sep 2026 11:46:18 +0000
- Citigroup (C) Stock May Be 31% Undervalued After Record Revenue Quarter
Citigroup stock has delivered a very strong 3 year return, yet current valuation checks suggest the shares may still trade at a discount to what some intrinsic value models imply. For investors, the puzzle is how to weigh that past performance against signals that both the Excess Returns model and market multiples point to undervaluation. Citigroup has returned 271.9% over the past 3 years, which puts extra focus on whether the current price still leaves room relative to underlying earning...
Sat, 05 Sep 2026 18:10:22 +0000
- Citigroup delays Fed rate cut forecast to June 2027
The bank had previously expected cuts in October and December 2026 and January 2027, but a stronger-than-expected August jobs report changed its outlook
Fri, 04 Sep 2026 17:59:07 +0000
- Citigroup Falls 1.1% as Its Rate-Cut Clock Jumps to 2027
The delayed easing cycle could protect interest income while making consumer credit increasingly expensive.
Fri, 04 Sep 2026 17:31:51 +0000